See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Best Buy Co., Inc. (BBY) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Best Buy Co., Inc. (BBY) - free report >>
Image: Bigstock
New Strong Buy Stocks for November 21st
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Best Buy Co., Inc. (BBY - Free Report) : This technology products retailer has witnessed the Zacks Consensus Estimate for its current year earnings surging 7.1% over the last 30 days.
BEST BUY Price and Consensus
BEST BUY Price and Consensus | BEST BUY Quote
The Charles Schwab Corporation (SCHW - Free Report) : This full-service investing solution provider has seen the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 30 days.
SCHWAB(CHAS) Price and Consensus
SCHWAB(CHAS) Price and Consensus | SCHWAB(CHAS) Quote
LHC Group, Inc. : This post-acute continuum of care provider has witnessed the Zacks Consensus Estimate for its current year earnings improving 3.9% over the last 30 days.
LHC GROUP LLC Price and Consensus
LHC GROUP LLC Price and Consensus | LHC GROUP LLC Quote
Ocwen Financial Corp. : This financial services holding company has seen the Zacks Consensus Estimate for its current year earnings soaring 28.7% over the last 30 days.
OCWEN FINL CORP Price and Consensus
OCWEN FINL CORP Price and Consensus | OCWEN FINL CORP Quote
Arbutus Biopharma Corporation (ABUS - Free Report) : This biopharmaceutical company has witnessed the Zacks Consensus Estimate for its current year earnings climbing 19.3% over the last 30 days.
ARBUTUS BIOPH Price and Consensus
ARBUTUS BIOPH Price and Consensus | ARBUTUS BIOPH Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Confidential from Zacks
Would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to access these private picks >>.